BioIntelligence Technologies
Turnkey solution of intelligent instruments & analytics to increase conversion yields and reduce losses in bioprocesses.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
* | N/A | Support Program | |
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 25 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
BioIntelligence 4.0 focuses on enabling intelligent biomanufacturing from research and development to production. The company offers powerful products designed to empower cutting-edge bioprocess development and biomanufacturing. Their flagship product, BioAnalyst, provides superior ease of use and powerful tools for real-time scientific and financial analysis, which accelerates the development of bioprocesses. BioIntelligence aims to accelerate access to new medications and greener chemicals, benefiting families, friends, fellow citizens, and the planet. The company operates in the biotechnology sector, serving clients involved in bioprocess development and manufacturing. BioIntelligence's business model revolves around providing advanced analytical tools and solutions that enhance the efficiency and effectiveness of biomanufacturing processes. The company generates revenue by offering these specialized tools and services to its clients.
Keywords: biomanufacturing, bioprocess, BioAnalyst, scientific analysis, financial analysis, biotechnology, R&D, production, medication, chemicals.